Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
50.06 USD | +3.11% | +15.14% | +719.54% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+719.54% | 510M | |
+9.44% | 115B | |
+12.76% | 107B | |
-13.33% | 22.31B | |
-3.44% | 21.6B | |
-5.12% | 18.23B | |
-38.57% | 17.62B | |
+7.25% | 14.26B | |
+35.27% | 12.37B | |
-26.67% | 8.28B |
- Stock Market
- Equities
- CRBP Stock
- News Corbus Pharmaceuticals Holdings, Inc.
- Corbus Gets Exclusive Rights to Develop, Commercialize Clinical-Stage Nectin-4 Antibody Drug Conjugate CRB-701